LexDanaLexDanabeta
Inventor

Wenhe ZHONG

Inventor
CN

Overview

3→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry10%
C07CAcyclic or carbocyclic compounds10%
PatentTitleYear
12,521,399Compound as voltage-gated sodium channel inhibitor202611,858,910Pyridinylmethylenepiperidine derivatives and uses thereof202411,285,153Substituted pyrimidine piperazine compound and use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to SUNSHINE LAKE PHARMA CO LTD (2)· patent assignee history
2022–2026Based in CN· patent location history
2026Patents assigned to GUANGZHOU FERMION TECH CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SUNSHINE LAKE PHARMA CO LTD22022–2024
GUANGZHOU FERMION TECH CO LTD12026
Locations
LocationPatentsSpan
CN32022–2026